1 / 46

Hypersensitivity reactions

Hypersensitivity reactions. marshnes@yahoo.com. Figure 1-32. Immune responses. Hypersensitivity Reactions. Harmful immune responses against harmless ‘environmental’ antigens (pollens, food, drugs)

drosario
Download Presentation

Hypersensitivity reactions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hypersensitivity reactions marshnes@yahoo.com

  2. Figure 1-32 Immune responses

  3. Hypersensitivity Reactions • Harmful immune responses against harmless ‘environmental’ antigens (pollens, food, drugs) • Classified into 4 type of reactions (Coombs & Gell), based on their effector mechanisms responsible for cell & tissue injuries

  4. Classification Allergy has many faces Antibody/B cell- mediated allergy

  5. Classification (contn’d) T cell-mediated Allergy

  6. Type I Hypersensitivity reactions(immediate type)* Allergy  the commonest type* IgE-mediated* Innocuous antigens: allergens

  7. IgE antibodies • Mediate mast cell activation degranulation • Via their Fce that interact to FceRI with high affinity  cytophilic (reaginic) Ab • Normal serum concentration: less than 1 mg/mL • Can rise to over 1000g/mL in severe atopy and helminthic infections • Has totally 5 Ig domains (4 constant and 1 variable heavy chains)

  8. FceR • Fce R I • A high affinity receptor • Mast cells, basophils, activated eosinophils • Fce R II (CD23) • A low affinity receptor • B cells, activated T cells, monocytes, eos, platelets

  9. Binding of IgE into its corresponding receptor: IgE-like domains of a-chain Mediate signal transduction

  10. Interaction of IgE antibodies to mast cell membrane

  11. The nature of allergens • High soluble proteins • Presented to immune system: at very low doses • Enzymes frequently triggers allergy • Cysteine protease of house dust mite(Der p 1) • Phospholipase A2 in bee venom • Others: pollen, mold spores, latex, certain drug, ie. penicillin

  12. Enzyme triggers allergy of the airway Dermatophagoides pteronyssimus Cysteine protease  Der p 1

  13. Enzyme allergens destroy airway epithelial cells

  14. The role of protease & protease-activated receptors (PARs) • Principles • Extracellular exo-and endogenous protease (mites, molds) react with cell-surface receptor leukocyte infiltration, amplify allergic responses • PARs • 7-transmembrane proteins coupled to G proteins: PAR-1,2,3 and 4. PAR-2 is the most important • Expressed on the cells involved in allergic rhinitis and asthma: epithelium, mast cells, eosinophils, neutrophils, monocytes-macrophages, lymphocytes, smooth muscle, endothelium, fibroblasts, neurons

  15. Molecular changes of PAR

  16. PAR stimulation • Increased intracell. Ca++, gene transcription • Epith.: opens tight junction, desquamation, produces cytokine, growth factors • Degranulates eosinophils, mast cells • Fibroblast: promotes proliferation, maturation, increase collagen prod. • Amplify IgE production • Bronchial muscle: contraction, proliferation • Trypsin (injured epith. cells), tryptase (mast cells)activ. PAR-2 • Chymase (mast cells) activ. PAR-2

  17. Factors leading to IgE production • Two main signals • Polarization into Th2 phenotype • IL-4, IL-5, IL-9, IL-13 • Stimulate IgE switch by B cells • IL-4, IL-13

  18. Candidate genes associated with atopy

  19. Contribution of genesand environmental factors Hygiene hypothesis (1989) Infections in early childhood Th1 response Non atopic

  20. Positive interaction between infection and development of atopy RSV infection  bronchiolitis Th2 cytokine production: IL-4 (away from IFN-g)

  21. New theory: Immunoregulatory disorders • Modern living  reducing contact with pathogens that prime Th1 response (1989) • Modern living conditions  defective maturation of Treg and APCreg

  22. The changes of theory? • Clinical evidence • Simultaneous autoimmunity-and IBD (Th1-mediated), and allergies (Th2-mediated) • Crucial factor: Teffector/Treg balance • Absence of immunoregulation develop Th1 or Th2-mediated inflammatory disorders • Depending on own Th1/Th2 bias, genetic background, immunological history

  23. The ‘old friends’ hypothesis • Harmless microorganisms (helminths, saprophytic mycobacteria, lactobacilli) • Less contact with ‘old friends’ in modern living • Allergy: less frequent in hookworm n schistosomiasis • Less lactobacilli in the guts of children  allergy; high doses of lactobacilli inhibits dev. of atopic eczema • M.vaccae  maturation of Treg treat pre-existing allergy

  24. modification of the hygiene hypothesis • “counter-regulation hypothesis”

  25. “Counter-regulation hypothesis” • All types of infection • Produce IL-10, TGF-b down regulate Th1 n Th2 responses • PAMP  TLRs of DC • LPS  TLR-4, CpG DNA  TLR-9, IFN-g  indoleamine 2,3-dioxygenase (IDO) • DC IDO  T reg  suppress Th2-driven inflammation

  26. Regulatory T cells (T reg) • Natural T reg (CD4CD25) • Defective in atopy (no suppression of Th2 cytokine production) • Defective in FoxP3  allergy, hyper IgE, airway inflammation

  27. CD4 Th17  Allergy/inflammation • IL-17

  28. IL-4 cytokine as IgE switch factor

  29. Role of mast cells • Effector cells of immediate hypersensitivity • Contain cytoplasmic granules, whose contents are the major mediators of allergic reaction • Vasoactive amines, lipid mediators, cytokines • Two subpopulations are detected • Connective tissue (CTMC) and mucosal (MMC) • Specific locations within the tissues • Close to blood vessels, nerve, smooth muscles

  30. Connective tissue- vs Mucosal-mast cells

  31. Molecules released by activated mast cells

  32. Mediators produced by mast cells

  33. Eosinophils • Reside in the connective tissue • Respiratory, gut, urogenital • Toxic granule proteins, radicals  parasites • Chemical mediators • Prostaglandins, leukotrienes, cytokines  inflammation • Chemokines • CXCL 8, Eotaxins: CCL11, CCL24, CCL26

  34. Toxic proteins and inflammatory mediators of eosinophils , eotaxins

  35. Sequence of events in allergic reaction • Initial exposure of antigen/allergen • Sampling by APC  processing & presentation • Stimulation of CD4+T cells  Th2 • IL-4 promotes B cells  IgE AFC • Sensitization of mast cells  degranulation • Immediate/early vascular & muscular changes • vascular permeability & vasodilatation, visceral and bronchial smooth muscle contraction • Late phase reactions, due to proinflammatory cytokines/chemokines • Infiltration & activation of inflammatory cells: eosinophils, basophils, neutrophils

  36. Local reactions in the skin: ‘Wheal and Flare’

  37. Hypersensitivity in the gut • Food allergy • Celiac disease (gluten-sensitive enteropathy) • a-gliadin • Inflammatory bowel disease (IBD)  autoimmune-based inflammatory reactions • overresponsiveness to commensal bacteria

  38. Immune response to gluten

  39. Activation of IEL CD8 T cells

  40. Approaches to the treatment of allergy

  41. Concluding remarks • Contributing factors to type I hypersensitivity reactions • Allergens • Proteins/molecules-bound to protein, low MW, low dose, enzymatically active, highly soluble • Combination of genetic and environmental factors • CD4+ Th cells, esp. Th2 responses • IL-4 and IL-13 cytokine production  IgE switch factor • IgE (cytophilic) antibodies • Mast cells • FceRI

More Related